Getting to Approval: Facilitating Agreements with the FDA

Time: 12:00 pm
day: Conference Day Two


  • An overview of the analytical characterization pathway to the clinic
  • What really matters with off-targets: Number of sites, amount of off-target editing, oncogenesis?
  • How should we account for population diversity when quantifying gene therapies?